San Diego, CA, United States of America

Manouchehr Shahbaz

USPTO Granted Patents = 8 

Average Co-Inventor Count = 5.3

ph-index = 4

Forward Citations = 46(Granted Patents)


Company Filing History:


Years Active: 2012-2023

Loading Chart...
8 patents (USPTO):

Title: Manouchehr Shahbaz: Innovator in Pharmaceutical Compositions

Introduction

Manouchehr Shahbaz is a prominent inventor based in San Diego, CA. He has made significant contributions to the field of pharmaceuticals, particularly in the development of new compositions aimed at treating chronic hyperkinetic movement disorders. With a total of 8 patents to his name, Shahbaz continues to push the boundaries of innovation in his field.

Latest Patents

One of his latest patents focuses on the formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2 (VMAT2). This invention relates to new pharmaceutical compositions comprising benzoquinoline compounds, which are designed to inhibit VMAT2 activity in subjects. This innovative approach aims to provide effective treatment options for individuals suffering from chronic hyperkinetic movement disorders.

Career Highlights

Shahbaz has established himself as a key figure in the pharmaceutical industry through his work at Auspex Pharmaceuticals, Inc. His research and inventions have garnered attention for their potential impact on treatment methodologies. His dedication to advancing pharmaceutical science is evident in his numerous patents and ongoing research efforts.

Collaborations

Throughout his career, Shahbaz has collaborated with notable professionals in the field, including Thomas George Gant and Andreas Sommer. These collaborations have further enriched his research and contributed to the development of innovative solutions in pharmaceuticals.

Conclusion

Manouchehr Shahbaz is a distinguished inventor whose work in pharmaceutical compositions has the potential to transform treatment options for chronic hyperkinetic movement disorders. His contributions to the field, marked by his patents and collaborations, highlight his commitment to innovation and excellence in pharmaceutical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…